SMTL ID : 5jfr.1

Potent, Reversible MetAP2 Inhibitors via Fragment Based Drug Discovery

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.60 Å

Oligo State

monomer

Ligands

2 x MN: MANGANESE (II) ION(Non-covalent)

MN.1: 4 residues within 4Å: Chain A: D.142, D.153, E.350 Ligands: MN.2 5 PLIP interactions: 3 interactions with chain A, 2 Ligand-Water interactions Metal complexes: A:D.142, A:D.153, A:E.350, H2O.1, H2O.2 MN.2: 7 residues within 4Å: Chain A: D.153, H.222, A.253, E.255, E.350 Ligands: MN.1, 6KP.5 5 PLIP interactions: 4 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:D.153, A:H.222, A:E.255, A:E.350, H2O.2

1 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)

DMS.3: 5 residues within 4Å: Chain A: Y.274, R.308, L.320, L.323, K.324 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:Y.274 Water bridges: A:C.271

1 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.4: 2 residues within 4Å: Chain A: V.132, Q.134 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:Q.134, A:Q.134

1 x 6KP: 7-fluoro-4-(5-methyl-3H-imidazo[4,5-b]pyridin-6-yl)-2,4-dihydropyrazolo[4,3-b]indole(Non-covalent)

6KP.5: 13 residues within 4Å: Chain A: F.110, P.111, H.122, D.153, H.222, I.229, H.230, E.255, H.273, M.275, A.305, Y.335 Ligands: MN.2 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:I.229, A:H.230, A:A.305 Hydrogen bonds: A:Y.335 Water bridges: A:H.230, A:H.230 pi-Stacking: A:Y.335 pi-Cation interactions: A:H.122, A:H.122, A:H.230

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

McBride, C. et al., Discovery of potent, reversible MetAP2 inhibitors via fragment based drug discovery and structure based drug design-Part 2. Bioorg.Med.Chem.Lett. (2016)

Release Date

2016-05-25

Peptides

Methionine aminopeptidase 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Methionine aminopeptidase 2

Related Entries With Identical Sequence